Piramal Pharma Limited, Ennore Express Highway, Ennore, Chennai – 600057, India
Piramal’s Ennore facility provides process development and early-phase clinical supplies for NCEs, as well as custom manufacturing services for RSMs, KSMs, and intermediates. The plant has a total capacity of 200+ MT per year. The facility has received regulatory accreditations from WHO GMP and India FDA
The facility specializes in route scouting and chemical development. It also offers the development of Phase I and II clinical batches of APIs in compliance with GMP. Our expertise extends to manufacturing intermediates at various scales, supported by strong experience in seamless scale-up processes.
Total capacity of our multi-purpose plant is 200+ metric tons per year. Our pilot plant can handle batches from 2 to 20 kilograms. Our cGMP Kilo lab is capable of handling 0.5 kg to 15 kg. We specialize in the commercial-scale execution of complex reactions like Cyanation, Hydrogenation, and Qzonolysis ensuring efficient production.
The facility specializes in route scouting and chemical development. It also offers the development of Phase I and II clinical batches of APIs in compliance with GMP. Our expertise extends to manufacturing intermediates at various scales, supported by strong experience in seamless scale-up processes.
Total capacity of our multi-purpose plant is 200+ metric tons per year. Our pilot plant can handle batches from 2 to 20 kilograms. Our cGMP Kilo lab is capable of handling 0.5 kg to 15 kg. We specialize in the commercial-scale execution of complex reactions like Cyanation, Hydrogenation, and Qzonolysis ensuring efficient production.
The facility offers expertise in asymmetric synthesis through stereo-selective methods utilizing chiral ligands, chiral pool chemistry, chiral reagents, and chemical resolution. It also specializes in heterocyclic synthesis, carbohydrate chemistry, organofluorine, transition metal-catalyzed reactions, and impurity profiling.
The facility offers comprehensive services for route scouting, chemical development, and seamless on-site manufacturing, ensuring efficient production processes. It specializes in supplying API Phase I and II clinical batches adhering to GMP standards.
The facility provides services for analytical method development & validation. It also offers impurity isolation and characterization, reference standard qualification, and conducting stability studies following ICH guidelines.
Established track record in developing intricate chemistries and scaling them up for commercial production.
Capability to integrate KSM/RSM production seamlessly with API and formulation manufacturing through our global network of facilities.
Embracing a culture of quality, we integrate rigorous quality checks and balances throughout our operations, ensuring consistent and exceptional product quality. Our teams are dedicated to upholding the highest quality standards at all stages of the development process.
Acquired by Nicholas Piramal from ICI
New R&D lab and a multi-purpose plant with capacity 26kL commissioned
Upgradation of the facility through program Thiruppam
Upgradation of production block
ETP-ZLD & GMP Kilo lab commissioned
